NCAPG is a novel biomarker of prognosis and is associated with immune cell infiltration in the tumor microenvironment, and it promotes cell proliferation and inhibits apoptosis by activating the PI3K/Akt/foxo4 pathway in hepatocellular carcinoma (44, 45). Here, FOXO4 is linked to hepatocellular carcinoma.